Maya Ghoussaini

机构：Regeneron (United States), Wellcome Sanger Institute, Open Targets · ORCID：0000-0002-2415-2143

发表论文 121 篇 · 总被引 15510 次 · h-index 47

代表论文

• An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci (2021 · Nature Genetics · 被引 658)
• The next-generation Open Targets Platform: reimagined, redesigned, rebuilt (2022 · Nucleic Acids Research · 被引 476)
• Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs (2022 · Nature Reviews Drug Discovery · 被引 276)
• Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery (2024 · Nucleic Acids Research · 被引 215)
• Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants (2023 · Nature Genetics · 被引 156)
• A deep catalogue of protein-coding variation in 983,578 individuals (2024 · Nature · 被引 119)